Life Science 2022

SPIE continues its expansion in the pharmaceutical industry and recruits for its Life Science department

Published on 24 March 2022

Paris, 24 March 2022 – The Industrie division of SPIE Industrie & Tertiaire, a French subsidiary of SPIE, the independent European leader in multi-technical services in the areas of energy and communications, is strengthening the expertise it applies to the pharmaceutical industry in order to support and meet the needs of companies in this booming sector. The company plans to strengthen its Life Science department by recruiting new consultants in the coming months.

A highly challenging industry on a very competitive and strategic market 

With a turnover of €62 billion in 2020, the French pharmaceutical industry is the fifth largest in the world. Stakeholders in the French pharmaceutical sector rely heavily on research and development in order to remain competitive, which requires regular equipment upgrades.

This strategic industry has benefited from recent recovery plans which aim to support its growth, accompany its digital transformation and supply it with new industrial capacity in France. Faced with these strategic challenges, the Industrie division of SPIE Industrie & Tertiaire has developed unique expertise in this sector.

In the Industrie division, we anticipated this development by integrating the pharmaceutical industry into our 2018 strategic plan. This special focus, comprising a specific action plan and precise positioning, has set us on a continuous growth trajectory on this market that requires experienced, reliable and agile partners, partners like the Industrie division itself”, explains Sophie Boget, Head of the Pharmacy Service within the Industrie division of SPIE Industrie & Tertiaire.

Unique expertise that benefits major groups 

As a long-standing industry partner, the Industrie division offers and provides diverse complementary services to pharmaceutical industry stakeholders. Its comprehensive and innovative service offering, which can be tailored to the needs of each individual customer, therefore allows it to contribute to industrial transformation.  

While the Industrie division’s expertise is already recognised in the areas of integration, industrial process management and clean room construction, it has also included a specific additional focus area since 2019. The Life Science department offers a consultancy service focused primarily on two areas of the pharmaceutical industry: project management assistance and support in validation and qualification processes (utilities, equipment, AGV robots, computerised systems, etc.) before production. This inclusion therefore strengthens the Industrie division’s position in the pharmaceutical industry.

Thanks to the synergies created, SPIE is consolidating its position as a key player that is capable of managing global projects from consultancy (project management) and the definition of process equipment to maintenance, including works and installation qualification and validation. This makes it a real asset on a global market where design and implementation times, as well as smooth transitions between project steps, are crucial.

The services we offer to the pharmaceutical industry are both technical and comprehensive. In addition to our long-standing presence in the sector (the Life Science department has been a part of the SPIE Group for 25 years), our expertise and human approach set us apart. For this reason, and because we want to support the growth we have seen, 2022 is a big year for recruitment”, explains Millàn Jamois, Business Manager within the Life Science department of the Industrie division of SPIE Industrie & Tertiaire. 

Recruitment to support this ambition: A 30% increase in staffing levels by the end of the year

In 2022, faced with strong market demand, the Industrie division of SPIE Industrie & Tertiaire is recruiting new talent for its Life Science service. Tasked with carrying out regular visits to some 20 customer sites, the team of 50 consultants is looking to welcome another 15 people with at least some initial experience in the pharmaceutical sector to its ranks. It is looking for technical specialists to fill posts in project management, equipment qualification and validation, and even data integrity , which is becoming increasingly important with the use of computerised systems. Supported on a daily basis by the management team, the LSS consultants also benefit from opportunities for internal mobility, which enable them to develop their career with the SPIE Group.